John F Crowley
CIK 1400973 · Executive Chairman · last filed 2024-03-15
John F Crowley is an Executive Chairman who has filed 233 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for FOLD, was dated Apr 15, 2024. Across all open-market trades the lifetime net is −$53.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $359.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$359.1K
3
233
-$53.88M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Executive Chairman | 991,908 | $14.49 | $14.37M | -$52.33M | 193 | 2024-03-15 |
| NTLA | Director | 11,716 | $11.10 | $130.0K | -$1.60M | 6 | 2023-06-16 |
| TRDA | Director | 37,864 | $6.05 | $229.1K | $48.6K | 4 | 2023-06-12 |
Recent Filings
233 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-15 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −29,183 | -$311.7K | EDGAR |
| 2024-04-01 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −29,181 | -$343.8K | EDGAR |
| 2024-03-15 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −29,181 | -$336.7K | EDGAR |
| 2024-03-15 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | −10,859 | -$934.7K | EDGAR |
| 2024-03-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −29,181 | -$389.5K | EDGAR |
| 2024-03-01 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −29,181 | -$374.1K | EDGAR |
| 2024-02-20 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | −126,583 | -$1.77M | EDGAR |
| 2024-02-15 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −31,614 | -$416.7K | EDGAR |
| 2024-02-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | −53,210 | -$672.5K | EDGAR |
| 2024-02-01 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Notice (144) | −31,614 | -$393.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.